Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

Promising results have been reported for patients with high-risk hematologic malignancies undergoing HLA-haploidentical bone marrow transplantation (haploBMT) with posttransplantation cyclophosphamide (PTCy), but there are few data on outcomes with myeloablative conditioning in this context. We repo...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Blood Adv
Päätekijät: Symons, Heather J., Zahurak, Marianna, Cao, Yilin, Chen, Allen, Cooke, Kenneth, Gamper, Christopher, Klein, Orly, Llosa, Nicolas, Zambidis, Elias T., Ambinder, Richard, Bolaños-Meade, Javier, Borrello, Ivan, Brodsky, Robert, DeZern, Amy, Gojo, Ivana, Showel, Margaret, Swinnen, Lode, Smith, B. Douglas, Luznik, Leo, Jones, Richard J., Fuchs, Ephraim J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2020
Aiheet:
Clinical Trials and Observations
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7448587/
https://ncbi.nlm.nih.gov/pubmed/32813874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001648
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia